Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index
about
Outcome assessment in Takayasu arteritisDamage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.Granulomatosis with polyangiitis in childhood.Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?New-generation therapy for ANCA-associated vasculitis.Granuloma in ANCA-associated vasculitides: another reason to distinguish between syndromes?Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?State of the art in the treatment of systemic vasculitides.Disease assessment in systemic vasculitis.Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Evaluation of damage in giant cell arteritis.The European Vasculitis Society 2016 Meeting Report.Issues in trial design for ANCA-associated and large-vessel vasculitis.Granulomatosis with Polyangiitis in Children
P2860
Q26782601-41F583BB-9FF5-4A19-AC00-88C12C285BC0Q30696868-9BE21332-DDF7-4647-A466-EA181548768BQ36820858-6E876508-682D-419E-84EF-4F070070354BQ37979678-5E9EBE14-0A44-46A4-9022-75DD8AD38032Q38100780-50D4B154-022E-462D-8B3B-416219792078Q38135271-AE0B6567-D4EB-4BC5-B1E1-1EB140501E2CQ38146909-6DAA9472-C7E1-4626-8FF2-607870F7D15AQ38204971-C87A27F0-75EE-4208-9BD0-E29E6DDA83E7Q38263514-FBF6E09B-8ABD-49B5-B307-7C7980215739Q38348251-0C7983B2-F831-450D-BBEE-FEEF65B49625Q38372499-06D13FF9-91DE-4E85-8FFF-6A1190E31EE4Q40801867-642B9976-9C30-42D1-AAC4-D16A17849C9CQ41690867-B1560C60-4ABB-48E0-8820-B889F55ED5F0Q46097662-B47EFE6A-3079-434E-A680-5CCA619CE208Q47107377-5F8C98CC-A345-49A4-9C80-CABC029388F7Q48937679-45D6A66F-8459-481E-A32A-C35B9101E9A5Q59160666-AC5243D9-EE69-4D9F-8B3F-96C8870D02DD
P2860
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Measurement of damage in syste ...... mbined Damage Assessment Index
@en
Measurement of damage in syste ...... bined Damage Assessment Index.
@nl
type
label
Measurement of damage in syste ...... mbined Damage Assessment Index
@en
Measurement of damage in syste ...... bined Damage Assessment Index.
@nl
prefLabel
Measurement of damage in syste ...... mbined Damage Assessment Index
@en
Measurement of damage in syste ...... bined Damage Assessment Index.
@nl
P2093
P2860
P356
P1476
Measurement of damage in syste ...... mbined Damage Assessment Index
@en
P2093
Alessandra Palmisano
Andrew Judge
Augusto Vaglio
Bo Baslund
Chetan Mukhtyar
Coen Stegeman
David Jayne
Denise Brown
Federico Alberici
Julia Holle
P2860
P356
10.1136/ARD.2009.122952
P407
P577
2010-08-24T00:00:00Z